Characterizing the PK/PD relationship for inhibition of capsaicin‐induced dermal vasodilatation by MK‐3207, an oral calcitonin gene related peptide receptor antagonist

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 79, Iss. 5, 2015-05 ,pp. : 831-837

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dose‐dependent suppression of human photoparoxysmal response with the competitive AMPA/kainate receptor antagonist BGG492: Clear PK/PD relationship

By  

EPILEPSIA, Vol. 56, Iss. 6, 2015-06 ,pp. : 924-932

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cervical cytological screening: Assessment of the Fournier® self‐sampling device in a cervical pathology outpatient clinic

By  

DIAGNOSTIC CYTOPATHOLOGY, Vol. 43, Iss. 10, 2015-10 ,pp. : 802-809

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prediction of Clinical Irrelevance of PK Differences in Atorvastatin Using PK/PD Models Derived From Literature‐Based Meta‐Analyses

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 1, 2014-07 ,pp. : 101-109

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetic (PK) drug interaction studies of cabozantinib: Effect of CYP3A inducer rifampin and inhibitor ketoconazole on cabozantinib plasma PK and effect of cabozantinib on CYP2C8 probe substrate rosiglitazone plasma PK

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 9, 2015-09 ,pp. : 1012-1023

John Wiley & Sons Inc

Access to resources Recommend Favorite